×
Entrez Id:
10111
Gene Symbol:
RAD50
RAD50
0.340
Biomarker
disease
CLINGEN
Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility.
14684699
2003
×
Entrez Id:
10111
Gene Symbol:
RAD50
RAD50
0.340
Biomarker
disease
CLINGEN
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.
16474176
2006
×
Entrez Id:
4683
Gene Symbol:
NBN
NBN
0.340
Biomarker
disease
CLINGEN
Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk.
23765759
2013
×
Entrez Id:
10111
Gene Symbol:
RAD50
RAD50
0.340
Biomarker
disease
CLINGEN
To evaluate the contribution of RAD50 to familial breast cancer , we screened the whole coding region for mutations in 435 UK and 46 Finnish familial breast cancer cases.
16385572
2006
×
Entrez Id:
84464
Gene Symbol:
SLX4
SLX4
0.330
Biomarker
disease
CLINGEN
Next-generation sequencing in familial breast cancer patients from Lebanon.
28202063
2017
×
Entrez Id:
84464
Gene Symbol:
SLX4
SLX4
0.330
Biomarker
disease
CLINGEN
Although this is the first study that describes a truncating SLX4 mutation in breast cancer patients, our data indicate that germline mutations in SLX4 are very rare and are unlikely to make a significant contribution to familial breast cancer .
22911665
2013
×
Entrez Id:
84464
Gene Symbol:
SLX4
SLX4
0.330
Biomarker
disease
CLINGEN
Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families.
23211700
2013
×
Entrez Id:
84464
Gene Symbol:
SLX4
SLX4
0.330
Biomarker
disease
CLINGEN
Mouse SLX4 is a tumor suppressor that stimulates the activity of the nuclease XPF-ERCC1 in DNA crosslink repair.
24726326
2014
×
Entrez Id:
84464
Gene Symbol:
SLX4
SLX4
0.330
Biomarker
disease
CLINGEN
Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
24733792
2014
×
Entrez Id:
84464
Gene Symbol:
SLX4
SLX4
0.330
Biomarker
disease
CLINGEN
Assessment of SLX4 Mutations in Hereditary Breast Cancers.
23840564
2013
×
Entrez Id:
84464
Gene Symbol:
SLX4
SLX4
0.330
Biomarker
disease
CLINGEN
Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia.
21240276
2011
×
Entrez Id:
84464
Gene Symbol:
SLX4
SLX4
0.330
Biomarker
disease
CLINGEN
SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.
21240277
2011
×
Entrez Id:
5965
Gene Symbol:
RECQL
RECQL
0.320
Biomarker
disease
CLINGEN
RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability.
17158923
2007
×
Entrez Id:
4595
Gene Symbol:
MUTYH
MUTYH
0.320
Biomarker
disease
CLINGEN
×
Entrez Id:
4361
Gene Symbol:
MRE11
MRE11
0.320
Biomarker
disease
CLINGEN
Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.
28073364
2017
×
Entrez Id:
4292
Gene Symbol:
MLH1
MLH1
0.320
Biomarker
disease
CLINGEN
The extracolonic cancer spectrum in females with the common 'South African' hMLH1 c.C1528T mutation.
18049911
2008
×
Entrez Id:
5965
Gene Symbol:
RECQL
RECQL
0.320
Biomarker
disease
CLINGEN
Germline RECQL mutations are associated with breast cancer susceptibility.
25915596
2015
×
Entrez Id:
4361
Gene Symbol:
MRE11
MRE11
0.320
Biomarker
disease
CLINGEN
The 3' to 5' exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks.
9651580
1998
×
Entrez Id:
5889
Gene Symbol:
RAD51C
RAD51C
0.320
Biomarker
disease
CLINGEN
Germline RAD51C mutations confer susceptibility to ovarian cancer.
22538716
2012
×
Entrez Id:
5965
Gene Symbol:
RECQL
RECQL
0.320
Biomarker
disease
CLINGEN
Our findings suggest that RECQL is a potential breast cancer susceptibility gene and that mutations in this gene contribute to familial breast cancer development.
25945795
2015
×
Entrez Id:
5965
Gene Symbol:
RECQL
RECQL
0.320
Biomarker
disease
CLINGEN
Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges.
18074021
2007
×
Entrez Id:
4361
Gene Symbol:
MRE11
MRE11
0.320
Biomarker
disease
CLINGEN
Altered expression of DNA double-strand break detection and repair proteins in breast carcinomas.
14511253
2003
×
Entrez Id:
5889
Gene Symbol:
RAD51C
RAD51C
0.320
Biomarker
disease
CLINGEN
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
20400964
2010
×
Entrez Id:
5889
Gene Symbol:
RAD51C
RAD51C
0.320
Biomarker
disease
CLINGEN
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
28418444
2017
×
Entrez Id:
5889
Gene Symbol:
RAD51C
RAD51C
0.320
Biomarker
disease
CLINGEN
Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.
22167183
2012